Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA

Abstract Cisplatin (DDP) is a common therapeutic option for non‐small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. Therefore, identifying novel biomarkers to improve the diagnosis and treatment of NSCLC is important. Ubiquitin‐specific protease (USP14)...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinmin Zhao, Xianghua Wu, Huijie Wang, Songtao Lai, Jialei Wang
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.237
Tags: Add Tag
No Tags, Be the first to tag this record!